Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
作者信息
Aboulghar M A, Mansour R T, Serour G I, Rhodes C A, Amin Y M
机构信息
Egyptian IVF-ET Center, Cairo, Egypt.
出版信息
J Assist Reprod Genet. 2000 May;17(5):298-301. doi: 10.1023/a:1009470602525.
Abstract
摘要
相似文献
1
Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
J Assist Reprod Genet. 2000 May;17(5):298-301. doi: 10.1023/a:1009470602525.
2
Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome.
Gynecol Endocrinol. 1995 Jun;9(2):97-102. doi: 10.3109/09513599509160197.
3
[Coasting: a response to excessive ovarian stimulation].
Gynecol Obstet Fertil. 2000 Feb;28(2):115-9.
4
The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Hum Fertil (Camb). 2006 Sep;9(3):175-80. doi: 10.1080/14647270600787575.
5
'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.
Hum Reprod. 1995 Dec;10(12):3107-9. doi: 10.1093/oxfordjournals.humrep.a135867.
6
Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.
Saudi Med J. 2018 Mar;39(3):290-295. doi: 10.15537/smj.2018.3.22331.
7
Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Curr Med Sci. 2019 Jun;39(3):431-436. doi: 10.1007/s11596-019-2055-x. Epub 2019 Jun 17.
8
Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Fertil Steril. 1990 Jan;53(1):92-6. doi: 10.1016/s0015-0282(16)53222-1.
9
Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program.
Gynecol Endocrinol. 2001 Jun;15(3):234-8. doi: 10.1080/gye.15.3.234.238.
10
Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
Asia Oceania J Obstet Gynaecol. 1990 Dec;16(4):297-300. doi: 10.1111/j.1447-0756.1990.tb00352.x.
引用本文的文献
1
The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization.
J Assist Reprod Genet. 2023 Nov;40(11):2681-2695. doi: 10.1007/s10815-023-02918-5. Epub 2023 Sep 15.
2
Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database.
Front Endocrinol (Lausanne). 2021 Dec 9;12:742089. doi: 10.3389/fendo.2021.742089. eCollection 2021.
3
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).
Reprod Biol Endocrinol. 2021 May 11;19(1):68. doi: 10.1186/s12958-021-00744-x.
4
ESHRE guideline: ovarian stimulation for IVF/ICSI.
Hum Reprod Open. 2020 May 1;2020(2):hoaa009. doi: 10.1093/hropen/hoaa009. eCollection 2020.
5
Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.
Int J Endocrinol. 2012;2012:540681. doi: 10.1155/2012/540681. Epub 2012 Feb 12.
本文引用的文献
1
"Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients.
Fertil Steril. 1998 Mar;69(3):454-60. doi: 10.1016/s0015-0282(97)00560-8.
2
Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.
Fertil Steril. 1997 Apr;67(4):724-7. doi: 10.1016/s0015-0282(97)81373-8.
3
Prospective controlled randomized study of in vitro fertilization versus intracytoplasmic sperm injection in the treatment of tubal factor infertility with normal semen parameters.
Fertil Steril. 1996 Nov;66(5):753-6. doi: 10.1016/s0015-0282(16)58630-0.
4
Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen.
J Assist Reprod Genet. 1996 Jan;13(1):38-42. doi: 10.1007/BF02068867.
5
'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.
Hum Reprod. 1995 Dec;10(12):3107-9. doi: 10.1093/oxfordjournals.humrep.a135867.
6
7
Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy.
Obstet Gynecol. 1993 Jan;81(1):108-11.
8
Rescue of menotrophin cycles prone to develop ovarian hyperstimulation.
Br J Obstet Gynaecol. 1987 Nov;94(11):1098-102. doi: 10.1111/j.1471-0528.1987.tb02297.x.
9
Ovarian hyperstimulation syndrome: an update review.
Obstet Gynecol Surv. 1989 Jun;44(6):430-40. doi: 10.1097/00006254-198906000-00004.
10
Modern management of ovarian hyperstimulation syndrome.
Hum Reprod. 1991 Sep;6(8):1082-7. doi: 10.1093/oxfordjournals.humrep.a137488.
Zotero 插件